Risperidone for delirium: where do we stand? | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article info

PostScript

Letter

Risperidone for delirium: where do we stand?

Authors

Mayra Q Bocatto Clinical Neuromodulation Laboratory, Santa Casa School of Medicine, São Paulo, Brazil PubMed articles Google scholar articles
Pedro Shiozawa Clinical Neuromodulation Laboratory, Santa Casa School of Medicine, São Paulo, Brazil PubMed articles Google scholar articles
Alisson Paulino Trevizol Clinical Neuromodulation Laboratory, Santa Casa School of Medicine, São Paulo, Brazil PubMed articles Google scholar articles
Quirino Cordeiro Clinical Neuromodulation Laboratory, Santa Casa School of Medicine, São Paulo, Brazil PubMed articles Google scholar articles

Correspondence to Professor Pedro Shiozawa. Department of Psychiatry, Santa Casa Medical School, Rua Major Maragliano, 241, Vila Mariana, São Paulo 01221-020, Brazil; pedroshiozawa{at}gmail.com.br

Citation

Bocatto MQ, Shiozawa P, Trevizol AP, et al

Risperidone for delirium: where do we stand?

European Journal of Hospital Pharmacy 2016;23:306.

Publication history

First published January 28, 2016.

Online issue publication

May 01, 2020

Article Versions

Previous version (27 March 2017).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/